Shanghai Rongtai Health Technology Corporation (603579.SH) intends to participate in the subscription of equity investment funds to further expand its investment areas.

Shanghai Rongtai Health Technology Corporation (603579.SH) announced that, in order to further expand its investment field while ensuring it meets its daily operating fund needs and overall investment risks are controllable, the company plans to use its own funds as a limited partner to jointly invest with general partners and executing partners Suzhou Vitelli Xin Chuangye Investment Management Co., Ltd. (referred to as "Vitelli Xin") and other limited partners to establish Ningbo Yongyuan Wen Zhong Entrepreneurial Investment Partnership Enterprise (Limited Partnership) on March 3, 2025, and has signed relevant agreements. The target total subscribed amount of the partnership enterprise is RMB 1 billion, of which the initial subscribed capital after the first delivery date is RMB 500 million (the final size is subject to the actual amount raised). The company will subscribe RMB 30 million with its own funds, holding a 6.00% stake in the initial subscribed capital of the partnership enterprise. The main investment areas of the partnership enterprise are mainly focused on making value investments in enterprises whose main business is digital transformation and empowerment of cross-border e-commerce, cross-border trade, and/or supporting cross-border e-commerce and cross-border trade.